Intention‐to‐treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?

Juan J. Araiz, M. Trinidad Serrano, Francisco A. García‐Gil, Elena M. Lacruz, Sara Lorente, José I. Sánchez, Miguel A. Suarez – 26 April 2016 – In human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients, the accelerated severity of liver disease, associated comorbidities, and mortality on the waiting list could change the possibility and results of liver transplantation (LT). Intention‐to‐treat survival analysis (ITTA) can accurately estimate the applicability and efficacy of LT.

Reply

Veronica Miller, Patrick Harrington, Anita Howe, Tara Kieffer, Johan Lennerstrand, Oliver Lenz, Erik Lontok, Fiona McPhee, Hongmei Mo, Neil Parkin, Tami Pilot‐Matias – 26 April 2016

Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management

Delphine Nicolle, Monique Fabre, Marina Simon‐Coma, Aurore Gorse, Roland Kappler, Lara Nonell, Mar Mallo, Hazar Haidar, Olivier Déas, Charlotte Mussini, Catherine Guettier, Marie‐José Redon, Laurence Brugières, Maria Rosa Ghigna, Elie Fadel, Louise Galmiche‐Rolland, Christophe Chardot, Jean‐Gabriel Judde, Carolina Armengol, Sophie Branchereau, Stefano Cairo – 26 April 2016 – Identification of new treatments for relapsing pediatric cancer is an unmet clinical need and a societal challenge.

Subscribe to